Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARM.L Regulatory News (ARM)

  • There is currently no data for ARM

Form 8.3 - ARM Holdings Plc

26 Aug 2016 13:40

RNS Number : 2777I
Societe Generale SA
26 August 2016
Β 

FORM 8.3

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

SociΓ©tΓ© GΓ©nΓ©rale S.A.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

ARM Holdings Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

25/08/2016

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

Ordinary shares 16,903,897 Shares interests and 117,878

short position

ADR (referencing the ordinary): 105,696 equivalent Shares interests and 119,826 equivalent Shares as short position

Where (1 ADR = 3 Ordinary)

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

17,009,593

1.21

237,704

0.02

(2) Cash-settled derivatives:

Β 

0

0.00

13,173,328

0.94

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

Β 

TOTAL:

17,009,593

1.21

13,411,032

0.95

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

Ordinary

Purchase

1,702

16.88

Ordinary

Purchase

1,305

16.88

Ordinary

Purchase

403

16.89

Ordinary

Purchase

1,632

16.88

Ordinary

Purchase

1,104

16.89

Ordinary

Purchase

544

16.89

Ordinary

Purchase

32,422

16.892968

ADR

Purchase

300

16.89

ADR

Purchase

300

16.88

ADR

Purchase

2,400

16.88

ADR

Purchase

7,476

16.86

ADR

Purchase

900

16.86

ADR

Purchase

300

16.86

Ordinary

Sale

2,434

16.88

Ordinary

Sale

110

16.88

Ordinary

Sale

2,819

16.88

Ordinary

Sale

279

16.88

Ordinary

Sale

1,909

16.88

Ordinary

Sale

900

16.88

Ordinary

Sale

332

16.88

Ordinary

Sale

6,587

16.880219

Ordinary

Sale

163

16.88

Ordinary

Sale

3,000

16.88

ADR

Sale

900

16.89

ADR

Sale

18

16.86

ADR

Sale

300

16.88

ADR

Sale

900

16.86

ADR

Sale

300

16.86

Total Purchases

50,788

Total Sales

20,951

Β (b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Ordinary

CFD

Increasing a Short Position

32,422

16.892968

Β 

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

Β 

Β 

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

Β 

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

Β 

Β 

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Β 

Date of disclosure:

26/08/2016

Contact name:

Olivier Vero

Telephone number:

+44 20 7676 6821 / 6969

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RETBDGDIIXDBGLL
Date   Source Headline
10th Oct 20137:00 amRNSInvestment in Cambridge Innovation Capital
1st Oct 201312:18 pmRNSTotal Voting Rights
20th Sep 20138:00 amRNSHolding(s) in Company
16th Sep 20138:55 amRNSHolding(s) in Company
9th Sep 20133:56 pmRNSDirector/PDMR Shareholding
2nd Sep 201310:55 amRNSTotal Voting Rights
29th Aug 20135:19 pmRNSDirector's share award
27th Aug 201310:04 amRNSHolding(s) in Company
22nd Aug 20138:57 amRNSHolding(s) in Company
15th Aug 201310:21 amRNSHolding(s) in Company
1st Aug 201312:21 pmRNSTotal Voting Rights
24th Jul 20137:00 amRNSHalf Yearly Report
22nd Jul 201312:18 pmRNSHolding(s) in Company
16th Jul 20135:07 pmRNSBLOCK LISTING SIX MONTHLY RETURN
10th Jul 201310:06 amRNSHolding(s) in Company
8th Jul 201310:06 amRNSHolding(s) in Company
1st Jul 20139:00 amRNSTotal Voting Rights
27th Jun 20131:45 pmRNSHolding(s) in Company
5th Jun 20139:15 amRNSHolding(s) in Company
4th Jun 20137:04 amRNSAppointment of New Director
3rd Jun 20133:28 pmRNSTotal Voting Rights
24th May 201312:35 pmRNSDirectors'/PDMRs' shareholding
22nd May 20139:43 amRNSHolding(s) in Company
21st May 20137:00 amRNSAnalyst and Investor Day
10th May 20131:40 pmRNSHolding(s) in Company
2nd May 20133:37 pmRNSAnnual General Meeting ("AGM")
1st May 20132:02 pmRNSTotal Voting Rights
23rd Apr 20137:00 amRNS1st Quarter Results
18th Apr 20139:45 amRNSHolding(s) in Company
2nd Apr 201310:05 amRNSTotal Voting Rights
19th Mar 201310:05 amRNSHolding(s) in Company
19th Mar 20137:00 amRNSARM HOLDINGS PLC ANNOUNCES CEO SUCCESSION
15th Mar 20132:50 pmRNSDirector/PDMR Shareholding
5th Mar 20139:59 amRNSDirector/PDMR Shareholding
1st Mar 201312:52 pmRNSPublication of ARM Holdings plc's Annual Report
1st Mar 201312:30 pmRNSTotal Voting Rights
28th Feb 20133:19 pmRNSDirector/PDMR Shareholding
22nd Feb 20134:13 pmRNSPDMRs' shareholding
20th Feb 20134:58 pmRNSDirector/PDMR Shareholding
14th Feb 201310:52 amRNSDirector/PDMR Shareholding
13th Feb 20132:04 pmRNSDirector/PDMR Shareholding
12th Feb 20135:37 pmRNSDirector/PDMR Shareholding
11th Feb 20134:11 pmRNSDirector/PDMR Shareholding
8th Feb 201311:46 amRNSDirector/PDMR Shareholding
7th Feb 201311:06 amRNSDirector/PDMR Shareholding
6th Feb 20134:56 pmRNSHolding(s) in Company
5th Feb 20137:00 amRNSFinal Results
1st Feb 20133:03 pmRNSTotal Voting Rights
22nd Jan 201312:39 pmRNSHolding(s) in Company
17th Jan 201310:19 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.